104
Pill imprint 104 has been identified as Sulfasalazine delayed release 500 mg.
Sulfasalazine is used in the treatment of ulcerative colitis; crohn's disease, maintenance; rheumatoid arthritis; alopecia; ulcerative colitis, maintenance (and more), and belongs to the drug classes 5-aminosalicylates, sulfonamides. There is no proven risk in humans during pregnancy.
Sulfasalazine 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Sulfasalazine delayed release Images
- Imprint:
-
104
- Strength:
- 500 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- povidone
magnesium stearate
silicon dioxide
propylene glycol
magnesium silicate
carnauba wax
white wax
acetone
alcohol
- Drug Class:
- 5-aminosalicylates
Sulfonamides - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Greenstone Limited
- National Drug Code (NDC):
- 59762-0104
Advertisement
More Sulfasalazine Delayed Release resources
- Sulfasalazine (Wolters Kluwer)
- Sulfasalazine Delayed-Release Tablets (Wolters Kluwer)
- sulfasalazine (Cerner Multum)
- Alti-Sulfasalazine Oral, Rectal (Micromedex) - Includes Dosage Information
- Salazopyrin Oral, Rectal (Micromedex) - Includes Dosage Information
- sulfasalazine Oral, Rectal (Micromedex) - Includes Dosage Information
- Sulfasalazine (AHFS DI)
- Sulfasalazine (FDA)
- Sulfasalazine Delayed-Release Tablets (FDA)
- Sulfasalazine (Wolters Kluwer)
Search Again
